Editor LSA

Penny Stocks in Focus - Save the World Air Inc, A.P. Pharma, Inc., Emo Capital Corp., Nuvilex Inc


Lewes, DE -- (SBWIRE) -- 07/25/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Save the World Air Inc (OTCBB:ZERO), A.P. Pharma, Inc. (OTCBB:APPA), Emo Capital Corp. (OTCBB:NUVI), Nuvilex Inc (OTCMKTS:NVLX)

Save the World Air Inc (OTCBB:ZERO) declined -5.80%, trading on 193,411 shares to end the trade at $1.30. If we look at its trading history of past 52 weeks, the share price suffered low of $0.42 and was moved to maximum level of $1.92.The stock changed hands in a range of $1.26 to $1.36, bringing its market capitalization at about $186.77 million. Save The World Air, Inc., a development stage enterprise, engages in designing, licensing, and developing products to commercialize energy efficient technologies. It offers energy efficiency technologies that assist in meeting global energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions.

Has ZERO Found The Bottom and Ready To Move Up? Find Out Here

A.P. Pharma, Inc. (OTCBB:APPA) complete the trading session at $0.470 with a total volume of 537,219 shares. The stock, on average, trades on a volume of 446,232 shares. In the past 52 weeks, the share price has not declined below $0.28 and above $0.89.It floated in a range of $0.46 to $0.48 during last trading session with a beta value of 0.51.Its market capitalization now moved to about $143.65 million. A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its Biochronomer technology consists of bioerodible polymers designed to release drugs over a defined period of time; and is applicable to a range of therapeutic areas, including pain management, prevention of nausea, control of inflammation, and treatment of ophthalmic diseases.

Can Investors Bet on APPA after this News update? Find out in this Research Report

Emo Capital Corp. (OTCBB:NUVI) was in a range of $0.07-$0.07 before closing at $0.0900. The share price hit its 52-week low of $0.04 and $0.63 was the best price. The stock completed the day with a total volume of 2.67 million shares versus an average volume of 273,708 shares. Emo Capital Corp., through its subsidiary, Nu Vitality Labs Inc., operates as a health and beauty company. It focuses on providing Web portal for its clients, where customers can receive diet/health and fitness coaching; communicate and interact with other individuals through the Nu Vitality Labs Health & Fitness social network; and purchase health and beauty supplements through the Nu Vitality Labs Beauty Store.

Is NUVI a Solid Investment at These Levels? Read This Report For Details

Nuvilex Inc (OTCMKTS:NVLX) added 0.35% yesterday, bringing its market capitalization around $65.94 million. The total number of shares changed hands during the session was 1.62 million shares as compared to average trading volume of 1.41 million shares. The share price after opening at $0.15 made a high of $0.15 and hovered above $0.14 to end the day at $0.144. Nuvilex, Inc, a biotechnology and life technology company, engages in the development and marketing of products for enhancing the health and well-being worldwide. The companys products include Cinnechol, a natural supplement to help maintain normal cholesterol levels and to support normal cardiovascular function.

What was the Moving Force behind NVLX on Bullish Run? Read This Research Report

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/